Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • CANCER RISK FROM AZATHIOPRINE...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE

CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE

Bibliographic Details
Main Authors: Connell, W, Kinlen, L, Ritchie, J, Balkwill, A, Lennardjones, J, Kamm, M
Format: Journal article
Published: 1994
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Azathioprine in inflammatory bowel disease, a safe alternative?
    by: A. A. Tanis
    Published: (1998-01-01)
  • CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
    by: Kinlen, L
    Published: (1977)
  • Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
    by: Fraser, A, et al.
    Published: (2002)
  • Increased incidence of azathioprine-induced toxicity in inflammatory bowel diseases compared to other diseases
    by: Weersma, R, et al.
    Published: (2004)
  • The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    by: Fraser, A, et al.
    Published: (2002)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs